PB
TRIB

Pinnacle Bancorp’s Trinity Biotech TRIB Stock Holding History

Pinnacle Bancorp’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$4K Buy
+151
New +$4.72K ﹤0.01% 581

Other funds holding TRIB

PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return

Pinnacle Bancorp's TRIB Position: Q1 2017 in Review

Pinnacle Bancorp opened a new position in Trinity Biotech (TRIB) in Q1 2017: 151 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #581 among its holdings.

67 funds tracked by Wall St. Rank hold TRIB as of Q1 2017.

  • Pinnacle Bancorp held 151 shares of Trinity Biotech worth $4K as of Q1 2017.
  • Trinity Biotech was a new Pinnacle Bancorp position in Q1 2017.
  • Trinity Biotech made up ﹤0.01% of Pinnacle Bancorp's portfolio in Q1 2017, its #581 holding.
  • 67 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2017.

Based on Pinnacle Bancorp's 13F filing for Q1 2017, filed 17 Apr 2017.